Tyriaq Signs Manufacturing Agreement with October Pharma

Tyriaq Signs Manufacturing Agreement with October Pharma

Tyriaq has signed a strategic manufacturing agreement with October Pharma to produce a selection of key products at October Pharma’s GMP-certified manufacturing site. This collaboration marks an important milestone in Tyriaq’s growth trajectory, enabling the company to manufacture its value-enhanced medicines and future fixed-dose combinations in a facility approved across GCC markets.

Through this partnership, Tyriaq strengthens its regional supply capabilities and opens the pathway for broader GCC market entry. The agreement also reinforces Tyriaq’s commitment to high-quality, locally produced pharmaceutical solutions that support healthcare systems across the region.